Erratum: Apolipoproteins, cardiovascular risk and statin response in type 2 diabetes: The Collaborative Atorvastatin Diabetes Study (CARDS)

Eitemau Tebyg

• Apolipoproteins, cardiovascular risk and statin response in type 2 diabetes: the Collaborative Atorvastatin Diabetes Study (CARDS).
  gan: Charlton-Menys, V, et al.
  Cyhoeddwyd: (2009)
• Targets of statin therapy: LDL cholesterol, non-HDL cholesterol, and apolipoprotein B in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS).
  gan: Charlton-Menys, V, et al.
  Cyhoeddwyd: (2009)
• Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: an analysis from the Collaborative Atorvastatin Diabetes Study (CARDS).
  gan: Colhoun, H, et al.
  Cyhoeddwyd: (2009)
• Safety of atorvastatin in the collaborative AtoRvastatin diabetes study (CARDS)
  gan: Newman, C, et al.
  Cyhoeddwyd: (2006)
• The safety and tolerability of atorvastatin 10 mg in the Collaborative Atorvastatin Diabetes Study (CARDS).
  gan: Newman, C, et al.
  Cyhoeddwyd: (2008)